Transmucosal Drug Delivery Devices: A Leading Driver Behind Growth In Chronic Diseases Propels Transmucosal Drug Delivery Devices Market Market Expansion in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Transmucosal Drug Delivery Devices Industry Market Size Be by 2025?
In the past few years, the market size of transmucosal drug delivery devices has significantly increased. The market is predicted to grow from the value of $50.24 billion in 2024 to $54.63 billion in 2025, with a compound annual growth rate (CAGR) of 8.7%. The substantial growth in the aforementioned period is due to several factors: the quest for quick relief from angina, the efficiency of sublingual delivery for immediate absorption into the bloodstream, the want to avoid gastrointestinal degradation, the evolution of buccal tablets, and the requirement for a non-invasive mode of delivering peptides and proteins.

What's the Long-Term Growth Forecast for the Transmucosal Drug Delivery Devices Market Size Through 2029?
Expectations are high for the transmucosal drug delivery devices market, with predictions of strong growth over the next few years. The market is slated to reach $76.06 billion by 2029, expanding at a compound annual growth rate (CAGR) of 8.6%. Various factors contribute to this projected growth, including the advent of smart drug delivery systems, rising chronic illness rates, an increased emphasis on personalized medicine, an elderly population requiring more medication, and heightened awareness. Other expected trends for the forecast period involve the broadening of therapeutic applications, the refinement of drug delivery devices to cater to personalized medicine, regulatory authorizations and guidelines, emerging markets, environmentally friendly devices, and innovative formulations.

View the full report here:
https://www.thebusinessresearchcompany.com/report/transmucosal-drug-delivery-devices-global-market-report

What Are the Key Growth Drivers Fueling the Transmucosal Drug Delivery Devices Market Expansion?
The transmucosal drug delivery devices market is predicted to grow due to an increasing trend of chronic diseases. Chronic diseases, generally characterized as conditions that gradually develop and persist over a long period, often necessitate continued medical supervision to manage symptoms and avert complications. These long-term illnesses are escalating due to factors like lifestyle changes, aging demographics, environmental influences, healthcare system issues, and urbanization. Transmucosal drug delivery devices offer controlled and efficient medication delivery, ensuring consistent therapeutic levels for symptom management and enhancing patient compliance in the face of chronic diseases. As an illustration, a report by the US-based charity, the Leukemia & Lymphoma Society (LLS), stated in August 2023, someone in the US is diagnosed with leukemia, lymphoma, or myeloma approximately every three minutes. In 2023, it is forecasted that roughly 184,720 individuals will receive these diagnoses, making up 9.4% of the estimated 1,958,310 new cancer cases for the year. Consequently, the rise in chronic diseases is a significant driver for the transmucosal drug delivery devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16812&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Transmucosal Drug Delivery Devices Market?
Major corporations in the transmucosal drug delivery device sector are designing advanced smart platforms such as unique transdermal patch delivery systems that amplify drug absorption, heighten patient adherence and boost convenience. These unique transdermal delivery technologies are specific systems owned by companies, designed to distribute medication via the skin, ensuring a controlled release and improved therapeutic results. To illustrate, Starton Therapeutics Inc, an American biotech firm, unveiled STARSILON in January 2024. This innovative proprietary transdermal patch delivery platform allows for an extended period of therapeutic delivery of difficult-to-formulate APIs. It broadens the transdermal drug delivery possibilities for hard-to-process active pharmaceutical ingredients (APIs) by improving therapeutic effectiveness with sustained delivery rates.

How Is the Transmucosal Drug Delivery Devices Market Segmented?
The transmucosal drug delivery devices market covered in this report is segmented -

1) By Type: Passive Transdermal Drug Delivery, Active Transdermal Drug Delivery
2) By Drug Type: Buccal Tablets, Oral Sprays, Sublingual Films And Wafers, Gels, Medicated Confectionery, Other Drug Types
3) By Indication: Pain Management, Addiction Treatment, Hormonal Therapies, Others Indications
4) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Hospitals

Subsegments:
1) By Passive Transdermal Drug Delivery: Reservoir Systems, Matrix Systems, Micro-Needle Systems, Pressure-Sensitive Adhesive Systems
2) By Active Transdermal Drug Delivery: Iontophoresis, Sonophoresis, Electroporation, Thermal Ablation, Microporation

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16812&type=smp

Which Companies Are Leading the Charge in Transmucosal Drug Delivery Devices Market Innovation?
Major companies operating in the transmucosal drug delivery devices market are Johnson & Johnson, Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Becton Dickinson and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup, Glenmark Pharmaceuticals Limited, Stevanato Group S.p.A, Lifevision Healthcare Private Limited, Noven Pharmaceuticals, SAVA Healthcare Limited, Antares Pharma Inc., Kaizen Pharmaceuticals Pvt. Ltd., Lucky Pharma Pvt. Ltd., Maya Biotech Pvt. Ltd, AdvaCare Pharma LLP, Satsuma Pharmaceuticals Inc., Biophar Lifesciences Private Limited, Fibovil Pharmaceuticals Private Limited, Slan Medicinal Holdings Ltd.

Which Regions Are Leading the Global Transmucosal Drug Delivery Devices Market in Revenue?
North America was the largest region in the transmucosal drug delivery devices market in 2024. The regions covered in the transmucosal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16812

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.